logo
Modella AI and AstraZeneca link for cancer clinical development

Modella AI and AstraZeneca link for cancer clinical development

Yahoo12 hours ago
Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development.
The partnership will give AstraZeneca access to Modella AI's multi-modal foundation models.
The agreement will enable the use of Modella AI's latest models, with rich feature extraction from different types of data, to speed up clinical development across AstraZeneca's worldwide oncology portfolio.
AstraZeneca oncology research and development (R&D) chief AI and data scientist Jorge Reis-Filho stated: 'At AstraZeneca, AI is integrated across every aspect of clinical development.
'Through the use of foundation models, combined with our unique datasets and AI expertise, we are confident in our strategy to accelerate development and increase the probabilities of success in our oncology clinical trials.'
AstraZeneca will use Modella AI's platform for cancer research R&D capabilities to improve biomarker discovery and clinical development while enhancing patient outcomes.
By integrating these advanced foundation models into its R&D pipeline, AstraZeneca seeks to enable data-driven discovery methods with increased speed.
Modella AI CEO Jill Stefanelli stated: 'Foundation models are transforming precision medicine. They are the backbone of AI-powered biomedical discovery and mark the first step toward fully autonomous AI agents.
'Our state-of-the-art multimodal foundation models provide powerful features from different data types for downstream tasks. When integrated with AstraZeneca's research engine, they will have the potential to accelerate data-driven development and enable the development of new AI agents that can automate complex R&D workflows.'
In June 2025, the US Food and Drug Administration (FDA) approved AstraZeneca and Daiichi Sankyo's Datroway (datopotamab deruxtecan) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that exhibits mutations in the epidermal growth factor receptor.
"Modella AI and AstraZeneca link for cancer clinical development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Detecting, monitoring skin cancers made easier with new screening technology
Detecting, monitoring skin cancers made easier with new screening technology

CBS News

time2 hours ago

  • CBS News

Detecting, monitoring skin cancers made easier with new screening technology

According to the American Cancer Society, more than 100,000 people will be diagnosed with melanoma this year. The good news is now that treatments have advanced, death rates have declined. Diagnostic tools have also vastly improved to detect and monitor skin cancers. Vectra WB180 system takes just seconds to photograph spots Dr. Jonathan Unger, medical director of the Waldman Melanoma and Skin Cancer Center at Mount Sinai, showed CBS News New York the Vectra WB180 system. "Basically, it is a total body photography system," Unger said. "We use 26 cameras to photograph the entire body ... And then the system takes all of these photos, high-resolution photos, and stitches them together into a three-dimensional avatar." The Vectra WB180 system uses 26 cameras to photograph the entire body so doctors can monitor spots on patients' skin. CBS News New York This is relatively new screening technology with about 100 machines across the country. Unger says it takes just a matter of seconds instead of all the time necessary to photograph each individual spot. "Gives us a memory of every spot on the patient's body, right? Once we have a moment in time, we can always look back and say, what did this thing look like? Was it there? Was it not there? Has it been changing?" he said. He adds accessing details of a patient's mole is much quicker, again, taking only seconds. There are additional benefits to this technology, as well. "Decide with greater certainty and more information whether something needs to be checked, tested, biopsied, et cetera," he said. "In our practice, it's really reduced the number of biopsies because a lot of our patients have hundreds, if not more than that, moles, all of which are irregular." He continued, "This allows us to have a higher level of confidence about what we're looking at and making a decision about." "It gives me the ability to take a deep breath and enjoy my life" Patient Jackie Mills has her spots scrutinized with the new machine after a scare several years ago. "In about 2020, I noticed a spot on my face that was new and rapidly changing," she said. But Mills says her dermatologist at that time wasn't that concerned. "I felt like it was getting bigger, changing colors, it was more jagged, and I really had to push and advocate for myself," she said. "Just had a gut feeling that something was wrong, and I was right." Mills was finally diagnosed with melanoma and had Mohs surgery to have the spot removed. "I had to kind of take it in for a minute and be like, I'm going to have a scar on my face for the rest of my life," she said. "It was that or not be here." Now she's checked every six months. "Not only is Dr. Unger looking at my spots, but he's using this machine to mathematically track what's going on from year to year. And I think that's just, it gives me the ability to take a deep breath and enjoy my life and not be constantly worried about melanoma coming back or being an issue," Mills said. The biggest safety tip from doctors is to use sunscreen every day. It can help prevent sunburn, premature aging and skin cancer.

Jim Cramer on Palantir: 'I Say it Can be Bought'
Jim Cramer on Palantir: 'I Say it Can be Bought'

Yahoo

time2 hours ago

  • Yahoo

Jim Cramer on Palantir: 'I Say it Can be Bought'

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the 25 stocks Jim Cramer recently shared insights on. Cramer highlighted his past predictions of the company stock going to $200 and said that he's 'sticking by that.' He commented: 'But what do we do with the very different set of winners for the first half? I want you to consider the GE Vernovas and the Howmets and the Palantirs, the stocks that are likely to finish the year dramatically higher from these exalted levels. What do you do with the stocks that have been on a run nonstop for 26 weeks, though? I think you send them on one of those two-week vacations like that Southeast Asia, Cape Town, maybe New Zealand. You pay no attention to them. Let them have a good time. Just take them off your screen, come back to them when the rotations run its course. A software engineer manipulating a vast network of code on virtual monitors. Palantir (NASDAQ:PLTR) develops software platforms that enable data integration, analysis, and decision-making for intelligence, defense, and commercial applications. The company provides tools like Gotham, Foundry, Apollo, and its AI platform to transform complex data into actionable insights. While we acknowledge the potential of PLTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nvidia's Arm chips rapidly gain share in server market as AI booms — Nvidia's Arm-powered GB200 servers surge as market reaches a record $95 billion in the first quarter
Nvidia's Arm chips rapidly gain share in server market as AI booms — Nvidia's Arm-powered GB200 servers surge as market reaches a record $95 billion in the first quarter

Yahoo

time2 hours ago

  • Yahoo

Nvidia's Arm chips rapidly gain share in server market as AI booms — Nvidia's Arm-powered GB200 servers surge as market reaches a record $95 billion in the first quarter

When you buy through links on our articles, Future and its syndication partners may earn a commission. The global server market experienced an unprecedented surge to nearly $100 billion in the first quarter as companies heavily invested in AI-related infrastructure, according to IDC, and 'accelerated' servers running Arm-based processors comprise one of the most rapidly growing categories, with Arm-powered server shipments rising 70% this year. It appears that the vast majority of these Arm-powered machines are Nvidia's GB200 NVL72 rack-scale solution, based on the Grace Blackwell platform, which features an Nvidia Grace CPU and eight B200 AI GPUs per server. Overall server purchases totaled $95.2 billion in Q1 2025, reflecting a 134.1% increase from the same period in 2024. This figure represents the fastest quarterly growth ever observed in this market, according to IDC. The widespread deployment of GPU-accelerated AI servers is fueling momentum, including those used by hyperscalers, with Nvidia's Arm-based Grace CPUs contributing to a 70% year-over-year increase in Arm server shipments this year. Based on this surge, the annual projection for the 2025 server market was revised upward to $366 billion, representing a 44.6% increase compared to the previous year. Spending on servers based on the x86 instruction set architecture (ISA) is expected to grow 39.9% for the year, reaching $283.9 billion. Meanwhile, systems using Arm and other non-x86 CPUs will gain even more, at a rate of 63.7% year-over-year, with projected sales of $82 billion in 2025. Sales of GPU-based AI and HPC servers are projected to grow by 46.7% in 2025, accounting for nearly half of all spending in this segment. This trend has been amplified by the need for massive computing power to support new AI workloads and training pipelines. Arm-based platforms are also gaining momentum, with shipment volumes projected to rise 70.0% compared to 2024. By the end of 2025, Arm systems are expected to represent approximately 21.1% of total server units shipped worldwide. This is considerably lower than Arm's long-term expectations of 50% market penetration. However, 21.1% is still a huge slice of the pie, considering that the lion's share of these CPUs are Nvidia's Grace processors. Spending on servers is expected to continue rising sharply in the coming years, starting at around $249 billion in 2024 and reaching $588 billion by 2029. The largest category in this period is Accelerated x86 (AI servers based on GPUs or AI accelerators with AMD or Intel processors), which is projected to grow from $112 billion in 2024 to $324 billion by 2029. However, Accelerated Arm machines are also set to expand rapidly, increasing more than threefold from $32 billion to $103 billion by 2029, reflecting a rather rapid adoption of Arm-based systems for AI and cloud workloads. Keep in mind that Accelerated Arm machines released between 2027 and 2028 can use not only Nvidia's processors, but also CPU designs from the 'NVLink Fusion camp,' such as those from Fujitsu, Marvell, MediaTek, and Qualcomm. Of course, it remains to be seen whether they will be able to capture significant market share. Accelerated Other Non-x86 (including FPGA and ASIC servers) is also set to grow, albeit modestly, reaching $31 billion in 2029. Demand for Accelerated AI servers will be driven by more advanced LLMs and LRMs, in addition to the speculation that artificial general intelligence (AGI) is possible. AGI would require even more compute performance than today's AI technologies, according to IDC. "The Stargate project re-announcement promised to invest up to $500 billion in AI infrastructure to help create artificial general intelligence (AGI)," said Kuba Stolarski, research vice president, Worldwide Infrastructure Research. "Shortly thereafter, the release of DeepSeek's R1 reasoning model caused concerns about the necessity of investing in so much infrastructure. [DeepSeek] R1 needed more infrastructure than was reported, and the evolution from simple chatbots to reasoning models to agentic AI will require several orders of magnitude more processing capacity, especially for inferencing. Improvements in the efficiency of model creation were expected and, in fact, a goal in the industry. Efficient models will use fewer resources, and therefore may scale better in multi-user environments, enabling high-level reasoning and possibly eventually leading to AGI." Meanwhile, spending on traditional servers (Non-Accelerated x86) will continue to rise steadily from $91 billion to $130 billion, but it'll become a smaller share of the overall market value. Unfortunately, IDC doesn't make forecasts about the adoption of general-purpose servers based on Arm CPUs, such as those from Arm itself, custom CPUs from hyperscale CSPs, or companies like Ampere Computing. Among geographic regions, the U.S. server market is expected to show the fastest expansion, with sales projected to increase 59.7% year-over-year, accounting for approximately 62% of the total revenue in 2025. China's market is also projected to experience substantial gains of 39.5%, accounting for over 21% of the quarterly server sales. Given that America and China are in an AI arms race, and both countries are unlikely to reduce their spending, such rapid growth is not surprising. Other areas of the world are seeing mixed results. Japan's market is projected to grow by 33.9%, while the Asia/Pacific region, excluding Japan, is expected to grow by 10.8%. Europe, the Middle East, and Africa are forecast to rise 7.0%, and Latin America will see a modest 0.7% advance. However, Canada stands out with a decline of 9.6%, as the prior year included an unusually large transaction. The demand for servers is white-hot across the globe, and it might be a sign that Jensen Huang's 50-year plan to build out AI infrastructure is already underway. Follow Tom's Hardware on Google News to get our up-to-date news, analysis, and reviews in your feeds. Make sure to click the Follow button. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store